BGI reveals analysis boost from GPUs; IBM's Watson gets help in tackling cancer care;

> BGI, the China-based DNA sequencing powerhouse, has beefed up its computational analysis of sequencing data with NVIDIA's graphics processor units (GPUs). Item

 > The Cedars-Sinai Samuel L. Oschin Comprehensive Cancer Institute in Los Angeles will aid health insurer WellPoint with the development of new clinical decision support tools for cancer care, using tools based on IBM's ($IBM) Watson technology. Article

> The New York Times profiled standout academic Eric Lander, founding director of the Broad Institute of Harvard and MIT. Article

> Certara, a St. Louis provider of R&D software, said that it has released version 6.0 of its D360 software, "with key enhancements that enable users to access data from clinical and preclinical data sources in addition to discovery. Release

> Patrick Soon-Shiong, who built is fortune in the pharmaceutical industry, is building a new empire in the digital health arena. Report

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.